Pharma Journalist -

The European Commission (EC) has approved Aubagio (teriflunomide) for the treatment of pediatric patients 10 to 17 years of age with relapsing-remitting multiple sclerosis (RRMS). The…
Read More...

SMi Group reports: Pharmaceutical Cleanroom Conference must attend workshops released which will convene in London on 5th October 2021. The highly anticipated 2nd annual conference…
Read More...

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company, and AM-Pharma, an emerging leader focused on the development of therapeutics that protect organ function in patients with severe…
Read More...

Danaher Corporation announced that Danaher has entered into a definitive agreement to acquire privately-held Aldevron, for a cash purchase price of approximately $9.6 billion. Danaher…
Read More...

Eisai Co., Ltd. and Bristol-Myers Squibb Company announced that the companies have entered into an exclusive global strategic collaboration agreement for the co-development and…
Read More...

Horizon Therapeutics plc announced that it has reached an agreement to purchase a drug product manufacturing facility from EirGen Pharma, an OPKO Health Company (Nasdaq: OPK) in…
Read More...

Kite, a Gilead Company and Shoreline Biosciences, Inc. (Shoreline), a biotechnology company developing intelligently designed allogeneic off-the-shelf, standardized and targeted natural…
Read More...

https://vimeo.com/563272966 At Online Seminar we know that in an era of increasing digital complexity you still want to connect with your target audience. Whether you communicate…
Read More...

Pfizer Inc.  and The Academic Research Organization (ARO) from the Hospital Israelita Albert Einstein today announced that the New England Journal of Medicine has published positive…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation (BTD) to 177Lu-PSMA-617, an investigational radioligand therapy for the…
Read More...